cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Pulmonx Corp
4 watching
Current Price
$9.02
$0.21
(2.38%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
337.42M
52-Week High
52-Week High
29.25
52-Week Low
52-Week Low
4.07
Average Volume
Average Volume
0.31M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization337.42M
icon52-Week High29.25
icon52-Week Low4.07
iconAverage Volume0.31M
iconDividend Yield--
iconP/E Ratio--
What does the Pulmonx Corp do?
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Read More
How much money does Pulmonx Corp make?
News & Events about Pulmonx Corp.
Ticker Report
10days ago
Pulmonx Co. (NASDAQ:LUNG Get Rating) has earned a consensus rating of Hold from the seven analysts that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and ...
Ticker Report
30days ago
Pulmonx (NASDAQ:LUNG Get Rating) had its price objective lowered by Morgan Stanley from $14.00 to $9.50 in a report issued on Friday, Benzinga reports. The firm currently has an equal weight rating on the stock. Morgan Stanleys price target points to a potential upside ...
Globe Newswire
3 months ago
REDWOOD CITY, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (Pulmonx), a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in two upcoming investor conferences in New York. Pulmonx management is ...
Business Wire
5 months ago
Pulmonx Corporation (Nasdaq: LUNG) (Pulmonx), a global leader in minimally invasive treatments for severe lung disease, announces the presentation of interim results from the CONVERT Study at the 2022 European Respiratory Society (ERS) International Conference. Data on the first 40 patients in the...
Ticker Report
6 months ago
Pulmonx (NASDAQ:LUNG Get Rating) had its price target cut by Canaccord Genuity Group from $34.00 to $31.00 in a report issued on Thursday, The Fly reports. They currently have a buy rating on the stock. LUNG has been the topic of several other research reports. Morgan Stanley boosted their ...
Frequently Asked Questions
Frequently Asked Questions
What is Pulmonx Corp share price today?
plus_minus_icon
Can Indians buy Pulmonx Corp shares?
plus_minus_icon
How can I buy Pulmonx Corp shares from India?
plus_minus_icon
Can Fractional shares of Pulmonx Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Pulmonx Corp stocks?
plus_minus_icon
What is today’s traded volume of Pulmonx Corp?
plus_minus_icon
What is today’s market capitalisation of Pulmonx Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Pulmonx Corp?
plus_minus_icon
What percentage is Pulmonx Corp down from its 52-Week High?
plus_minus_icon
What percentage is Pulmonx Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$9.02
$0.21
(2.38%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00